(5-chloro-1,3-dimethyl-1H-pyrazol-4-yl)methanol | 105466-41-9

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 芳基卤化物
• 英文名称: (5-chloro-1,3-dimethyl-1H-pyrazol-4-yl)methanol
• 英文别名: 5-chloro-1,3-dimethyl-4-hydroxymethylpyrazole；(5-chloro-1,3-dimethylpyrazol-4-yl)methanol
• CAS: 105466-41-9
• 化学式: C₆H₉ClN₂O
• mdl: MFCD06202854
• 分子量: 160.603
• InChiKey: MJRUYPWXZWNTHR-UHFFFAOYSA-N

物化性质

• 沸点：
  282.5±35.0 °C(Predicted)
• 密度：
  1.32±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  38
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (5-chloro-1,3-dimethyl-1H-pyrazol-4-yl)methanol 在 四溴化碳 、 三苯基膦 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 生成 4-(bromomethyl)-5-chloro-1,3-dimethyl-1H-pyrazole
  参考文献：
  名称：

  EP1362850

  摘要：

  公开号：
• 作为产物：
  描述：

  5-氯-1,3-二甲基-1H-吡唑-4-甲醛 在 sodium tetrahydroborate 作用下， 以 四氢呋喃 为溶剂， 生成 (5-chloro-1,3-dimethyl-1H-pyrazol-4-yl)methanol
  参考文献：
  名称：

  [EN] SUBSTITUTED PYRIDIZINONE DERIVATIVES AS PDE10 INHIBITORS
  [FR] DÉRIVÉS DE PYRIDIZINONE SUBSTITUÉS UTILISÉS EN TANT QU'INHIBITEURS DE LA PDE10

  摘要：

  本发明涉及一种具有式（I）的取代吡啶酮化合物，其可用作治疗与磷酸二酯酶10（PDE10）相关的中枢神经系统疾病的治疗剂。本发明还涉及利用这种化合物治疗神经学和精神疾病，如精神分裂症、精神病或亨廷顿病，以及与纹状体功能不足或基底节功能障碍相关的疾病。

  公开号：

  WO2014139150A1

文献信息

• Synthesis of Sulfoximines and Sulfilimines with Aryl and Pyrazolylmethyl Substituents
  作者：Olga García Mancheño、Jonathan Dallimore、Andrew Plant、Carsten Bolm

  DOI：10.1002/adsc.200900729

  日期：2010.2.15

  Sulfoximines bearing pyrazolylmethyl and aryl substituents, which are relevant to the crop protection industry, and their corresponding sulfilimine intermediates, have been prepared from sulfide precursors by either iron-catalyzed nitrogen transfer reactions or metal-free imination procedures. Whereas the former approach leads to N-nosyl-substituted products, the latter affords N-cyano derivatives

  带有吡唑基甲基和芳基取代基的与农作物保护工业有关的亚磺酰亚胺及其相应的亚硫亚胺中间体，是由硫化物前体通过铁催化的氮转移反应或无金属的亚胺化方法制备的。前一种方法可产生N-烷基取代的产物，而后者可提供N-氰基衍生物。
• Oxime ether compound and agricultural or horticultural bactericide
  申请人：——

  公开号：US20040116480A1

  公开（公告）日：2004-06-17

  An oxime ether compound represented by the formula [I] or a salt thereof which have excellent bactericidal activity and are useful as an agricultural or horticultural fungicide. [I] (In the formula, R 1 represents halogeno, hydroxy, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 alkyl substituted by C 1-6 alkoxy, cyano, nitro, C 2-6 alkenyl, C 2-6 haloalkenyl, C 2-6 alkynyl, amino, mono(C 1-6 alkyl)amino, di(C 1-6 alkyl)amino, C 3-6 cycloalkyl, carboxyl, C 1-6 alkoxycarbonyl, etc.; R 2 represents hydrogen, C 1-6 alkyl, C 3-6 cycloalkyl, C 1-6 haloalkyl, etc.; R 3 and R 4 each represents hydrogen or C 1-6 alkyl; k is an integer of 1 to 4; and A represents the heterocyclic group shown in the description.) 1

  一种由式[I]表示的肟醚化合物或其盐，具有优异的杀菌活性，并可用作农业或园艺杀菌剂。[I]（在该式中，R1代表卤素，羟基，C1-6烷基，C1-6卤代烷基，C1-6烷氧基，C1-6烷基被C1-6烷氧基取代，氰基，硝基，C2-6烯基，C2-6卤代烯基，C2-6炔基，氨基，单（C1-6烷基）氨基，二（C1-6烷基）氨基，C3-6环烷基，羧基，C1-6烷氧羰基等；R2代表氢，C1-6烷基，C3-6环烷基，C1-6卤代烷基等；R3和R4各代表氢或C1-6烷基；k为1至4的整数；A代表说明中所示的杂环基）。
• PYRIMIDINES AS NOVEL THERAPEUTIC AGENTS
  申请人：Université Laval

  公开号：US20150225423A1

  公开（公告）日：2015-08-13

  The present invention features compounds having the Formula (Ia) and (Ib) (e.g., a compound of any of Formulas ((Ia-2)-(Ia-21)), including other tautomers, stereoisomers, E/Z stereoisomers, prodrugs, pharmaceutically acceptable salts, and compositions thereof. The invention also features methods for treating or preventing pain (e.g., neuropathic pain), inflammation, or epilepsy in a patient by administering an effective amount of a compound of Formula (Ia) or (Ib). The invention also features a method for treating or preventing pain (e.g., neuropathic pain), inflammation, or epilepsy in a patient that includes administering to a patient in need thereof an effective amount of a compound of Formula (IIa) or (IIb) (e.g., a compound of any of Formulas ((IIa-2)-(IIa-6)). The compounds described herein (e.g., a compound of Formulas (Ia), (Ib), (IIa), or (IIb)) can also be used as anticonvulsants.

  本发明涉及具有式(Ia)和(Ib)的化合物(例如，任何公式((Ia-2)-(Ia-21))的化合物，包括其他互变异构体、立体异构体、E/Z立体异构体、前药、药学上可接受的盐及其组合物。本发明还涉及通过给患者施用式(Ia)或(Ib)的化合物的有效量来治疗或预防疼痛(例如，神经痛)、炎症或癫痫的方法。本发明还涉及一种治疗或预防疼痛(例如，神经痛)、炎症或癫痫的方法，包括向需要的患者施用式(IIa)或(IIb)的化合物的有效量(例如，任何公式((IIa-2)-(IIa-6))的化合物)。本文所描述的化合物(例如，公式(Ia)、(Ib)、(IIa)或(IIb)的化合物)也可用作抗惊厥剂。
• Pyrimidines as novel therapeutic agents
  申请人：Attardo Giorgio

  公开号：US09040538B2

  公开（公告）日：2015-05-26

  The present invention features compounds having the Formula (Ia) and (Ib) (e.g., a compound of any of Formulas ((Ia-2)-(Ia-21)), including other tautomers, stereoisomers, E/Z stereoisomers, prodrugs, pharmaceutically acceptable salts, and compositions thereof. The invention also features methods for treating or preventing pain (e.g., neuropathic pain), inflammation, or epilepsy in a patient by administering an effective amount of a compound of Formula (Ia) or (Ib). The invention also features a method for treating or preventing pain (e.g., neuropathic pain), inflammation, or epilepsy in a patient that includes administering to a patient in need thereof an effective amount of a compound of Formula (IIa) or (IIb) (e.g., a compound of any of Formulas ((IIa-2)-(IIa-6)). The compounds described herein (e.g., a compound of Formulas (Ia), (Ib), (IIa), or (IIb)) can also be used as anticonvulsants.

  本发明涉及具有公式(Ia)和(Ib)的化合物（例如，任何公式((Ia-2)-(Ia-21))的化合物，包括其他互变异构体、立体异构体、E/Z立体异构体、前药、药学上可接受的盐和组合物）。本发明还涉及通过给予公式(Ia)或(Ib)的化合物的有效量来治疗或预防患者的疼痛（例如，神经痛）、炎症或癫痫的方法。本发明还涉及一种治疗或预防患者的疼痛（例如，神经痛）、炎症或癫痫的方法，包括向需要的患者给予公式(IIa)或(IIb)的化合物的有效量（例如，任何公式((IIa-2)-(IIa-6))的化合物）。本文描述的化合物（例如，公式(Ia)、(Ib)、(IIa)或(IIb)的化合物）也可用作抗癫痫药。
• SUBSTITUTED PYRIDIZINONE DERIVATIVES AS PDE10 INHIBITORS
  申请人：KUDUK Scott D.

  公开号：US20160016947A1

  公开（公告）日：2016-01-21

  The present invention is directed to substituted pyridizinone compounds of formula I which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

  本发明涉及公式I的取代吡啶嗪酮化合物，其作为治疗与磷酸二酯酶10（PDE10）相关的中枢神经系统疾病的治疗剂是有用的。本发明还涉及使用这些化合物治疗神经和精神障碍，例如精神分裂症、精神病或亨廷顿病，以及与纹状体低功能或基底节功能障碍相关的疾病。